Cresemba Ευρωπαϊκή Ένωση - Ελληνικά - EMA (European Medicines Agency)

cresemba

basilea pharmaceutica deutschland gmbh - isavuconazole - Ασπεργίλλωση - cresemba ενδείκνυται σε ενήλικες για τη θεραπεία:της εισβολής aspergillosismucormycosis σε ασθενείς για τους οποίους η αμφοτερικίνη Β είναι inappropriateconsideration θα πρέπει να δοθούν επίσημες οδηγίες για την κατάλληλη χρήση των αντιμυκητιασικών.

Ontilyv Ευρωπαϊκή Ένωση - Ελληνικά - EMA (European Medicines Agency)

ontilyv

bial portela & companhia s.a. - opicapone - Νόσος του Πάρκινσον - Αντιπαρκινσονικά φάρμακα - ontilyv is indicated as adjunctive therapy to preparations of levodopa/ dopa decarboxylase inhibitors (ddci) in adult patients with parkinson’s disease and end-of-dose motor fluctuations who cannot be stabilised on those combinations.

Plerixafor Accord Ευρωπαϊκή Ένωση - Ελληνικά - EMA (European Medicines Agency)

plerixafor accord

accord healthcare s.l.u. - plerixafor - multiple myeloma; hematopoietic stem cell transplantation - Ανοσοδιεγερτικά, - adult patientsplerixafor accord is indicated in combination with granulocyte-colony stimulating factor (g-csf) to enhance mobilisation of haematopoietic stem cells to the peripheral blood for collection and subsequent autologous transplantation in adult patients with lymphoma or multiple myeloma whose cells mobilise poorly (see section 4. paediatric patients (1 to less than 18 years)plerixafor accord is indicated in combination with g-csf to enhance mobilisation of haematopoietic stem cells to the peripheral blood for collection and subsequent autologous transplantation in children with lymphoma or solid malignant tumours, either:- pre-emptively, when circulating stem cell count on the predicted day of collection after adequate mobilization with g-csf (with or without chemotherapy) is expected to be insufficient with regards to desired hematopoietic stem cells yield, or- who previously failed to collect sufficient haematopoietic stem cells (see section 4.

Incivo Ευρωπαϊκή Ένωση - Ελληνικά - EMA (European Medicines Agency)

incivo

janssen-cilag international n.v. - telaprevir - Ηπατίτιδα c, Χρόνια - Αντιιικά για συστηματική χρήση - incivo σε συνδυασμό με πεγκυλιωμένη ιντερφερόνη άλφα και ριμπαβιρίνη, ενδείκνυται για τη θεραπεία από τον γονότυπο 1 της χρόνιας ηπατίτιδας c σε ενήλικες ασθενείς με αντιρροπούμενη ηπατική νόσο (συμπεριλαμβανομένης της κίρρωσης):ποια είναι η θεραπεία αφελείς, που έχουν προηγουμένως υποβληθεί σε θεραπεία με ιντερφερόνη άλφα (πεγκυλιωμένη ή μη πεγκυλιωμένη) μόνη της ή σε συνδυασμό με ριμπαβιρίνη, συμπεριλαμβανομένων relapsers, μερική ανταπόκριση και μηδενική ανταπόκριση.

SMOFKABIVEN INJ.EM.INF Ελλάδα - Ελληνικά - Εθνικός Οργανισμός Φαρμάκων

smofkabiven inj.em.inf

fresenius kabi hellas ae Λεωφ. Κηφισίας 64Α, 151 25 Μαρούσι Αττικής 6542909 - alanine; arginine; glycine; histidine; isoleucine; leucine; lysine acetate; l-methionine; phenylalanine; proline; l-serine; taurine; threonine; tryptophan, l-; tyrosine; valine; calcium chloride dihydrate; sodium glycerophosphate; magnesium sulfate heptahydrate; potassium chloride; sodium acetate trihydrate; zinc sulfate; dextrose(glucose) monohydrate; soya oil; triglycerides medium chain; olive oil, refined; fish oil (omega-3 polyunsaturated fatty acids) - inj.em.inf (ΓΑΛΑΚΤΩΜΑ ΓΙΑ ΕΓΧΥΣΗ) - alanine 14g; arginine 12g; glycine 11g; histidine 3g; isoleucine 5g; leucine 7,4g; lysine acetate 9,3g; l-methionine 4,3g; phenylalanine 5,1g; proline 11,2g; l-serine 6,5g; taurine 1g; threonine 4,4g; tryptophan, l- 2g; tyrosine 0,4g; valine 6,2g; calcium chloride dihydrate 0,56g; sodium glycerophosphate 4,18g; magnesium sulfate heptahydrate 1,2g; potassium chloride 4,48g; sodium acetate trihydrate 3,4g; zinc sulfate 0,013g; dextrose(glucose) monohydrate 462g; soya oil 60g; triglycerides medium chain 60g; olive oil, refined 50g; fish oil (omega-3 polyunsaturated fatty acids) 3g - combinations

SMOFKABIVEN PERIPHERAL INJ.EM.INF Ελλάδα - Ελληνικά - Εθνικός Οργανισμός Φαρμάκων

smofkabiven peripheral inj.em.inf

fresenius kabi hellas ae Λεωφ. Κηφισίας 64Α, 151 25 Μαρούσι Αττικής 6542909 - dextrose(glucose) monohydrate; alanine; arginine; glycine; histidine; isoleucine; leucine; lysine acetate; l-methionine; phenylalanine; proline; l-serine; taurine; threonine; tryptophan, l-; tyrosine; valine; calcium chloride dihydrate; sodium glycerophosphate; magnesium sulfate heptahydrate; potassium chloride; sodium acetate trihydrate; zinc sulfate heptahydrate; soybean oil; triglycerides medium chain; refined olive oil; fish oil (omega-3 polyunsaturated fatty acids) - inj.em.inf (ΓΑΛΑΚΤΩΜΑ ΓΙΑ ΕΓΧΥΣΗ) - dextrose(glucose) monohydrate 143g; alanine 14g; arginine 12g; glycine 11g; histidine 3g; isoleucine 5g; leucine 7,4g; lysine acetate 9,3g; l-methionine 4,3g; phenylalanine 5,1g; proline 11,2g; l-serine 6,5g; taurine 1g; threonine 4,4g; tryptophan, l- 2g; tyrosine 0,4g; valine 6,2g; calcium chloride dihydrate 0,74g; sodium glycerophosphate; magnesium sulfate heptahydrate 2,47g; potassium chloride 4,48g; sodium acetate trihydrate 5,62g; zinc sulfate heptahydrate 0,023g; soybean oil 60g; triglycerides medium chain 60g; refined olive oil 50g; fish oil (omega-3 polyunsaturated fatty acids) 30g - combinations

SMOFKABIVEN® EXTRA NITROGEN INJ.EM.INF Ελλάδα - Ελληνικά - Εθνικός Οργανισμός Φαρμάκων

smofkabiven® extra nitrogen inj.em.inf

fresenius kabi hellas ae Λεωφ. Κηφισίας 64Α, 151 25 Μαρούσι Αττικής 6542909 - alanine; arginine; glycine; histidine; isoleucine; leucine; lysine acetate; methionine; phenylalanine; proline; serine; taurine; threonine; tryptophan, l-; tyrosine; valine; calcium chloride dihydrate; sodium glycerophosphate; magnesium sulfate; potassium chloride; sodium acetate trihydrate; zinc sulfate heptahydrate; dextrose(glucose) monohydrate; soya bean oil, hydrogenated; triglycerides medium chain; olive oil, refined; fish oil (omega-3 polyunsaturated fatty acids) - inj.em.inf (ΓΑΛΑΚΤΩΜΑ ΓΙΑ ΕΓΧΥΣΗ) - alanine 14g; arginine 12g; glycine 11g; histidine 3g; isoleucine 5g; leucine 7,4g; lysine acetate 9,3g; methionine 4,3g; phenylalanine 5,1g; proline 11,2g; serine 6,5g; taurine 1g; threonine 4,4g; tryptophan, l- 2,2g; tyrosine 0,4g; valine 6,2g; calcium chloride dihydrate 0,434g; sodium glycerophosphate 3,48g; magnesium sulfate 0,931g; potassium chloride 3,48g; sodium acetate trihydrate 2,47g; zinc sulfate heptahydrate 0,01g; dextrose(glucose) monohydrate 462g; soya bean oil, hydrogenated 60g; triglycerides medium chain 60g; olive oil, refined 50g; fish oil (omega-3 polyunsaturated fatty acids) 30g - combinations

SMOFKABIVEN® LOW OSMO PERIPHERAL INJ.EM.INF Ελλάδα - Ελληνικά - Εθνικός Οργανισμός Φαρμάκων

smofkabiven® low osmo peripheral inj.em.inf

fresenius kabi hellas ae Λεωφ. Κηφισίας 64Α, 151 25 Μαρούσι Αττικής 6542909 - alanine; arginine; glycine; histidine; isoleucine; leucine; lysine acetate; methionine; phenylalanine; proline; serine; taurine; threonine; tryptophan, l-; tyrosine; valine; calcium chloride dihydrate; magnesium sulfate heptahydrate; potassium chloride; sodium acetate trihydrate; sodium glycerophosphate; zinc sulfate heptahydrate; dextrose(glucose) monohydrate; soybean oil; triglycerides medium chain; refined olive oil; fish oil (omega-3 polyunsaturated fatty acids) - inj.em.inf (ΓΑΛΑΚΤΩΜΑ ΓΙΑ ΕΓΧΥΣΗ) - alanine 14g; arginine 12g; glycine 11g; histidine 3g; isoleucine 5g; leucine 7,4g; lysine acetate 9,3g; methionine 4,3g; phenylalanine 5,1g; proline 11,2g; serine 6,5g; taurine 1g; threonine 4,4g; tryptophan, l- 2g; tyrosine 0,4g; valine 6,2g; calcium chloride dihydrate 0,74g; magnesium sulfate heptahydrate 2,47g; potassium chloride 4,48g; sodium acetate trihydrate 5,62g; sodium glycerophosphate 4,18g; zinc sulfate heptahydrate 0,023g; dextrose(glucose) monohydrate 130g; soybean oil 60g; triglycerides medium chain 60g; refined olive oil 50g; fish oil (omega-3 polyunsaturated fatty acids) 30g - combinations

Orserdu Ευρωπαϊκή Ένωση - Ελληνικά - EMA (European Medicines Agency)

orserdu

stemline therapeutics b.v. - elacestrant - Νεοπλάσματα του μαστού - Ενδοκρινική θεραπεία - orserdu monotherapy is indicated for the treatment of postmenopausal women, and men, with estrogen receptor (er) positive, her2-negative, locally advanced or metastatic breast cancer with an activating esr1 mutation who have disease progression following at least one line of endocrine therapy including a cdk 4/6 inhibitor.

NUTRIFLEX® OMEGA PERI INJ.EM.INF Ελλάδα - Ελληνικά - Εθνικός Οργανισμός Φαρμάκων

nutriflex® omega peri inj.em.inf

b. braun melsungen a.g, germany carl-braun-strasse 1, 34212 melsungen 0049 56 61 71 2849 - isoleucine; leucine; lysine hydrochloride; methionine; phenylalanine; threonine; tryptophan, l-; valine; arginine; histidine hydrochloride; alanine; aspartic acid; glutamic acid; glycine; proline; serine; sodium hydroxide; sodium chloride; sodium acetate trihydrate; potassium acetate; magnesium acetate tetrahydrate; calcium chloride dihydrate; dextrose(glucose) monohydrate; monobasic sodium phosphate dihydrate; zinc acetate dihydrate; triglycerides medium chain; soya oil; omega-3-acid triglycerides - inj.em.inf (ΓΑΛΑΚΤΩΜΑ ΓΙΑ ΕΓΧΥΣΗ) - isoleucine 1,872g; leucine 2,504g; lysine hydrochloride 2,272g; methionine 1,568g; phenylalanine 2,808g; threonine 1,456g; tryptophan, l- 0,456g; valine 2,08g; arginine 2,16g; histidine hydrochloride 1,352g; alanine 3,88g; aspartic acid 1,2g; glutamic acid 2,8g; glycine 1,32g; proline 2,72g; serine 2,4g; sodium hydroxide 0,64g; sodium chloride 0,865g; sodium acetate trihydrate 0,435g; potassium acetate 2.354g; magnesium acetate tetrahydrate 0,515g; calcium chloride dihydrate 0,353g; dextrose(glucose) monohydrate 70,4g; monobasic sodium phosphate dihydrate 0,936g; zinc acetate dihydrate 5,28g; triglycerides medium chain 20g; soya oil 16g; omega-3-acid triglycerides 4g - combinations